Improving survival of stage II‐III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy

BACKGROUND: There is no consistent evidence about the appropriate treatment strategies for gastric signet ring cell carcinoma (GSRC) to improve prognosis. We conducted a population‐based study to examine the effects of combined modality therapies on survival outcomes using the Surveillance, Epidemio...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yang, Zhu, Zhikai, Ma, Fuhai, Xue, Liyan, Tian, Yantao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520351/
https://www.ncbi.nlm.nih.gov/pubmed/32744431
http://dx.doi.org/10.1002/cam4.3342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520351/
https://www.ncbi.nlm.nih.gov/pubmed/32744431
http://dx.doi.org/10.1002/cam4.3342

Ejemplares similares